Skip to main content

What the FDA labels say about taking them together

Atorvastatin and danazol

Danazol's FDA label of April 30, 2020 names atorvastatin in its drug interactions section; the atorvastatin labels PlainMeds reads (2) do not name danazol. The danazol label: “The risk of myopathy and rhabdomyolysis is increased by concomitant administration of danazol with statins such as simvastatin, atorvastatin and lovastatin.”

Check it at the source: the atorvastatin FDA label on DailyMed (effective April 15, 2024, Viatris Specialty LLC); the danazol FDA label on DailyMed (effective April 30, 2020, Lannett Company, Inc.).

What does the atorvastatin label say about danazol?

Atorvastatin's label (effective April 15, 2024) and its 1 other brand-application label do not name danazol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lipitor), NDA020702 (Upjohn), as published by Viatris Specialty LLC, effective April 15, 2024 (SPL set a60cc18b-0631-4cf0-b021-9f52224ece65), via openFDA; the full label on DailyMed

What does the danazol label say about atorvastatin?

Danazol label, drug interactions

The risk of myopathy and rhabdomyolysis is increased by concomitant administration of danazol with statins such as simvastatin, atorvastatin and lovastatin.

Source: FDA drug label (Danazol), Lannett Company, Inc., effective April 30, 2020 (SPL set f2c9b713-aafc-49ca-866e-334d9b5c2e2d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

59Atorvastatin generic labelers
4Danazol generic labelers
AtorvastatinDanazol
Labeled forHigh cholesterol, Angina, High triglycerides, Heart attack and coronary artery diseasen/a
Boxed warningNoYes
Pharmacy cost (NADAC)$0.0228 per tablet 10 mg tablet$2.65 per capsule 200 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?